Loading...
Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test
Primary human papillomavirus (HPV) testing (without concurrent Pap tests) every 3 years is under consideration in the United States as an alternative to the two recommended cervical cancer screening strategies: primary Pap testing every 3 years, or concurrent Pap and HPV testing (“cotesting”) every...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4111283/ https://ncbi.nlm.nih.gov/pubmed/25038467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju153 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|